FXR activation lowers plasma glucose, improves insulin resistance, and reduces hepatic inflammation and fibrosis markers, whereas FXR deficiency impairs glucose tolerance (Mudaliar et al., 2013). This evidence concerns the gene NR1H4 and Insulin resistance.